Based on the results obtained using HDAC inhibition in FUS-ALS (Arenas et al., 2020; Kuta et al., 2020), we propose a molecular mechanism that could link the different HDACs to FUS mislocalization and FUS-derived toxicity (Figures 3, 4). This evidence concerns the gene HDAC9 and amyotrophic lateral sclerosis.